- EMBL does not work with a third party travel agent nor request credit card details. For more information please see our SCAM ALERT.
- Please only submit applications for fellowships directly to EMBL when you submit your abstract. Do not respond to any other third parties soliciting applications.
- Harry Noller (University of California, Santa Cruz) has confirmed to give a keynote history talk
- Registration is now open for this event. Please register online.
- Do you have something to tweet? Use this hashtag #EMBOprotein
Translational control is a major focus of attention that extends to many fields, including developmental biology, neurobiology, cell physiology, disease, synthetic and systems biology, etc. In addition to translation of messenger RNA, the conference will feature advances in the field of non-coding RNAs, both small (miRNA) and large (lncRNA), that influence the translation process and its machinery. Novel, powerful high-throughput technologies and structural advances will also be central, as they are pushing the field forward in manners that were unthinkable only few years ago, and are helping to create a “systems” view of translation.
With the increasing appreciation of the integration between different steps of gene expression, the conference will explore the connections between translation, mRNA turnover, nonsense-mediated decay, RNA localisation, and nuclear events such as transcription and splicing. Finally, many alternatives to the classical “one message makes one protein” concept are being unraveled which increase the potential for regulation. These alternatives will be featured, as well as the role of translational regulation in diseases as diverse as cancer, neurological disorders or infectious diseases.
- Translation initiation
- Non-coding RNA
- Development and disease
- Interconnections between translation and other processes
- Ribonucleoprotein complexes
- The ribosome
- Systems approaches
This conference is partnered with Cold Spring Harbor Laboratory (CSHL).